Kura Oncology Inc (KURA)

R&D Expense Growth

-5.17%

Quarterly · Period ending:

KURA logo

KURA R&D Expense Growth

Latest reported-5.17%
KURA Quarterly R&D Growth (QoQ) (0.00% → -5.17%)
High-resolution chart · PNG

KURA r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Kura Oncology Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-5.1668%
1.3275%
-5.154%
8.1596%
12.1702%
7.0905%
25.3255%
4.979%
9.5373%
11.4807%
10.9281%
4.0664%
11.8688%
11.1346%
-9.23%
2.9475%
15.9948%
-0.2052%
-6.3084%
6.1355%
3.6902%
15.9781%
5.5599%
21.2017%
8.9225%
-6.6028%
7.3684%
9.6154%
10.1907%
-14.0847%
3.6275%
1.6121%
-0.7781%
42.456%
13.6796%
26.3623%
2.5213%
0.1817%
3.5177%
7.6985%
6.1734%
-9.0749%
10.3128%
5.317%
21.3065%
0%
-100%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.